| Design and virtual screening of novel fluoroquinolone analogs as effective mutant DNA GyrA inhibitors against urinary tract infection-causing fluoroquinolone resistant … S Balasubramaniyan, N Irfan, A Umamaheswari, A Puratchikody RSC advances 8 (42), 23629-23647, 2018 | 31 | 2018 |
| Computational lock and key and dynamic trajectory analysis of natural biophors against COVID-19 spike protein to identify effective lead molecules I Navabshan, B Sakthivel, R Pandiyan, MG Antoniraj, S Dharmaraj, ... Molecular biotechnology 63 (10), 898-908, 2021 | 27 | 2021 |
| Marine biome-derived secondary metabolites, a class of promising antineoplastic agents: A systematic review on their classification, mechanism of action and future perspectives A Sugumaran, R Pandiyan, P Kandasamy, MG Antoniraj, I Navabshan, ... Science of the Total Environment 836, 155445, 2022 | 17 | 2022 |
| The synthesis and biological evaluation of virtually designed fluoroquinolone analogs against fluoroquinolone-resistant Escherichia coli intended for UTI treatment S Balasubramaniyan, N Irfan, S kumar Chinnaiyan, U Appavoo, ... New Journal of Chemistry, 2020 | 14 | 2020 |
| Conceptual design of hybrid PCSK9 lead inhibitors against coronary artery disease A Puratchikody, N Irfan, S Balasubramaniyan Biocatalysis and Agricultural Biotechnology 17, 427-440, 2019 | 14 | 2019 |
| Impact of untreated sewage and thermal effluent discharges on the air-sea CO2 fluxes in a highly urbanized tropical coastal region C Muthukumar, S Balasubramaniyan, D Garlapati, MD Bharathi, ... Marine Pollution Bulletin 175, 113166, 2022 | 7 | 2022 |
| Bioactive Efficacy of Novel Carboxylic Acid from Halophilic Pseudomonas aeruginosa against Methicillin-Resistant Staphylococcus aureus H Santhaseelan, VT Dinakaran, B Sakthivel, M Somasundaram, ... Metabolites 12 (11), 1094, 2022 | 6 | 2022 |
| QSAR and lead optimization N Ramalakshmi, S Arunkumar, S Balasubramaniyan Computer Applications in Drug Discovery and Development, 80-100, 2019 | 4 | 2019 |
| Target Identification of HDAC8 Isoform for the Treatment of Cancer. InComputer Applications in Drug Discovery and Development 2019 (pp. 140-172) A Umamaheswari, A Puratchikody, S Balasubramaniyan IGI Global, 0 | 4 | |
| QSAR and Lead Optimization. InComputer Applications in Drug Discovery and Development 2019 (pp. 80-100) N Ramalakshmi, S Arunkumar, S Balasubramaniyan IGI Global, 0 | 4 | |
| Bioisosteric replacements of tyrosine kinases inhibitors to make potent and safe chemotherapy against malignant cells N Irfan, S Balasubramaniyan, DM Ali, A Puratchikody Journal of Biomolecular Structure and Dynamics 41 (19), 9437-9447, 2023 | 3 | 2023 |
| Virtually screened novel sulfathiazole derivatives as a potential drug candidate for methicillin-resistant Staphylococcus aureus and multidrug-resistant tuberculosis S Nagendran, S Balasubramaniyan, N Irfan Journal of Biomolecular Structure and Dynamics 41 (11), 5086-5095, 2023 | 3 | 2023 |
| Microbial degradation of quinoline by immobilized bacillus subtilis S Balasubramaniyan, TMU Mary, M Swaminathan Biocatalysis and Agricultural Biotechnology 47, 102604, 2023 | 3 | 2023 |
| Solvent effects, chemical reactivity, docking and antimicrobial activity of silver and gold nanocages glimepiride: Experimental and theoretical calculations G Venkatesh, P Vennila, S Balasubramaniyan Chemical Physics Impact 8, 100498, 2024 | 2 | 2024 |
| Orally bioavailable 4-phenoxy-quinoline compound as a potent Aurora kinase B relocation blocker for cancer treatment J Li, T Zhang, Q Shi, G Lv, X Zhou, N Choudhry, J Kalashova, C Yang, ... ACS Pharmacology & Translational Science 6 (8), 1155-1163, 2023 | 2 | 2023 |
| Microbial and Solar Photocatalytic Degradation of Pyridine S Balasubramaniyan, HA Khan, M Swaminathan ES Energy & Environment 22, 971, 2023 | 1 | 2023 |
| Isolation and Identification of Bioactive Compounds with Antimicrobial Activity from Marine Facultative Anaerobe, Bacillus subtilis M Kotakonda, M Marappan, P Dharmar, B Sakthivel, P Sunnapu Current Pharmaceutical Biotechnology 24 (5), 698-707, 2023 | 1 | 2023 |
| An orally bioavailable 4-phenoxy-quinoline compound as a potent AURKB relocation blocker for cancer treatment J Li, T Zhang, Q Shi, G Lv, X Zhou, N Choudhry, J Kalashova, C Yang, ... BioRxiv, 2023.01. 29.526078, 2023 | 1 | 2023 |
| Quinoline analogue as a potential inhibitor of SARS-CoV-2 main protease: ADMET prediction, molecular docking and dynamics simulation analysis P Kumar, SS Mahantheshappa, S Balasubramaniyan, ND Satyanarayan, ... European Journal of Chemistry 14 (1), 30-38, 2023 | | 2023 |
| Target Identification of HDAC8 Isoform for the Treatment of Cancer A Umamaheswari, A Puratchikody, S Balasubramaniyan Computer Applications in Drug Discovery and Development, 140-172, 2019 | | 2019 |
Irfan NavabshanCrescent Institute of Science and Technology在 crescent.education 的电子邮件经过验证
Irfan NavabshanCrescent Institute of Science and Technology在 crescent.education 的电子邮件经过验证